Back to top

Will ChemoCentryx (CCXI) Continue to Surge Higher?

Read MoreHide Full Article

As of late, it has definitely been a great time to be an investor in ChemoCentryx, Inc. (CCXI - Free Report) . The stock has moved higher by 7.7% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider CCXI’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as CCXI has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


ChemoCentryx, Inc. (CCXI) - free report >>

More from Zacks Tale of the Tape

You May Like